1. Home
  2. VKTX vs EXEEZ Comparison

VKTX vs EXEEZ Comparison

Compare VKTX & EXEEZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • EXEEZ
  • Stock Information
  • Founded
  • VKTX 2012
  • EXEEZ N/A
  • Country
  • VKTX United States
  • EXEEZ United States
  • Employees
  • VKTX N/A
  • EXEEZ N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • EXEEZ Oil & Gas Production
  • Sector
  • VKTX Health Care
  • EXEEZ Energy
  • Exchange
  • VKTX Nasdaq
  • EXEEZ Nasdaq
  • Market Cap
  • VKTX 7.2B
  • EXEEZ 8.4B
  • IPO Year
  • VKTX 2015
  • EXEEZ N/A
  • Fundamental
  • Price
  • VKTX $49.58
  • EXEEZ $85.22
  • Analyst Decision
  • VKTX Strong Buy
  • EXEEZ
  • Analyst Count
  • VKTX 10
  • EXEEZ 0
  • Target Price
  • VKTX $109.80
  • EXEEZ N/A
  • AVG Volume (30 Days)
  • VKTX 6.8M
  • EXEEZ N/A
  • Earning Date
  • VKTX 10-23-2024
  • EXEEZ N/A
  • Dividend Yield
  • VKTX N/A
  • EXEEZ N/A
  • EPS Growth
  • VKTX N/A
  • EXEEZ N/A
  • EPS
  • VKTX N/A
  • EXEEZ N/A
  • Revenue
  • VKTX N/A
  • EXEEZ N/A
  • Revenue This Year
  • VKTX N/A
  • EXEEZ N/A
  • Revenue Next Year
  • VKTX N/A
  • EXEEZ N/A
  • P/E Ratio
  • VKTX N/A
  • EXEEZ N/A
  • Revenue Growth
  • VKTX N/A
  • EXEEZ N/A
  • 52 Week Low
  • VKTX $10.51
  • EXEEZ N/A
  • 52 Week High
  • VKTX $99.41
  • EXEEZ N/A
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 31.07
  • EXEEZ N/A
  • Support Level
  • VKTX $62.50
  • EXEEZ N/A
  • Resistance Level
  • VKTX $70.41
  • EXEEZ N/A
  • Average True Range (ATR)
  • VKTX 5.16
  • EXEEZ 0.00
  • MACD
  • VKTX -2.29
  • EXEEZ 0.00
  • Stochastic Oscillator
  • VKTX 1.99
  • EXEEZ 0.00

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: